Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

3 Malfunctioning Battery Stocks That Could Mega-Charge by 2025

These three battery stocks have been hit hard in 2022, but could see a nice rally over the next three years.

Will the Housing Market Bounce Back in 2022?

Investors are asking if the housing market will bounce back in 2022. That's difficult to answer, but here's what investors may be able expect.

Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi

Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session.

Why Is Palisade Bio (PALI) Stock Up 130% Today?

Today's rally in PALI stock appears to be tied directly to an FDA announcement that it's fast tracking a key drug from the company.

Why Is DraftKings (DKNG) Stock Down 10% Today?

Today, investors in DraftKings and DKNG stock are pricing in the effects of a hack which took place this past weekend.